Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Comparision between Genpharmasec Rights Issue 2024 and Grasim Industries Rights Issue 2024.
Find important information like Listing Exchange, Terms of payment and Entitlement Ratio for Genpharmasec Rights Issue 2024 and Grasim Industries Rights Issue 2024. Genpharmasec Rights Issue 2024 is listed on BSE while Grasim Industries Rights Issue 2024 is listed on BSE, NSE.
| Genpharmasec Limited | Grasim Industries Ltd. | |
|---|---|---|
| Logo |  |
 |
| Listing At | BSE | BSE, NSE |
| Terms of Payment | Full amount of Rs.1.75 per Equity Share is payable on application. |
The amount of Rs. 453 per Rights Equity Share is to be paid on the Application. The balance of Rs 1,359 will be paid on up to three subsequent calls as determined by the Board. |
| Entitlement | 1 Rights Equity Share(s) for every 1 fully paid-up Equity Shares held on Record Date | 6 Rights Equity Share(s) for every 179 fully paid-up Equity Shares held on Record Date |
| Application Form | Application Form  |
Application Form |
| Letter of Offer | Letter of Offer |
Letter of Offer |
| Registrar | Purva Sharegistry India Pvt Ltd | Kfin Technologies Limited |
| Lead Managers | Axis Capital Limited Bofa Securities India Limited Jefferies India Private Limited Jm Financial Limited Kotak Mahindra Capital Company Limited SBI Capital Markets Limited |
The issue size of Genpharmasec Rights Issue 2024 rights issue is ₹48.45 Crores, whereas Grasim Industries Rights Issue 2024 rights issue size is ₹3,999.80 Crores.
| Genpharmasec Limited | Grasim Industries Ltd. | |
|---|---|---|
| Issue Size | 27,68,59,850 shares | 2,20,73,935 shares |
| Issue Size (Amount) | ₹48.45 Crores | ₹3,999.80 Crores |
| Issue Price | ₹1.75 per share | ₹1812 per share |
| Face Value | ₹1 per share | ₹2 per share |
Find all the important dates related to the rights issue. The record date of Genpharmasec Rights Issue 2024 is Jan 09, 2024 while record date of Grasim Industries Rights Issue 2024 is Jan 10, 2024.
| Genpharmasec Limited | Grasim Industries Ltd. | |
|---|---|---|
| Record Date | Jan 09, 2024 | Jan 10, 2024 |
| Credit of Rights Entitlements | Jan 16, 2024 | |
| Bid/Offer Opens On | Jan 23, 2024 | Jan 17, 2024 |
| Renunciation of Rights Entitlements | Feb 02, 2024 | Jan 23, 2024 |
| Bid/Offer Closes On | Feb 13, 2024 | Jan 29, 2024 |
| Deemed Date of Allotment | Feb 16, 2024 | Feb 08, 2024 |
| Credit Date | Feb 21, 2024 | Feb 09, 2024 |
| Listing Date | Feb 26, 2024 | Feb 12, 2024 |
Comparison of Genpharmasec Rights Issue 2024 and Grasim Industries Rights Issue 2024 financial data, including total revenue, PAT, and net worth. The table below also includes a list of all relevant documents like the Application Form and Letter of Offer. Related Parties like Lead Manager and Registrar are also mentioned in this section.
| Genpharmasec Limited | Grasim Industries Ltd. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financial | Genpharmasec Limited Financial Information (Restated)Genpharmasec Limited's revenue decreased by -6.56% and profit after tax (PAT) rose by 637.15% between the financial year ending with March 31, 2023 and March 31, 2022.
|
Grasim Industries Ltd. Financial Information (Restated Consolidated)Grasim Industries Ltd.'s revenue increased by 25.61% and profit after tax (PAT) dropped by -1.14% between the financial year ending with March 31, 2023 and March 31, 2022.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
